Pinnacle Associates LTD Teva Pharmaceutical Industries LTD Transaction History

Pinnacle Associates LTD

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 25, 2023	BUY	$7.95 - $9.48 $795 - $948	100 Added 0.19%	53,775 $0
Q3 2022 Oct 31, 2022	BUY	$6.86 - $11.95 $249,018 - $433,785	36,300 Added 208.92%	53,675 $433,000
Q2 2022 Aug 02, 2022	SELL	$7.38 - $10.4 $72,729 - $102,492	-9,855 Reduced 36.19%	17,375 $131,000
Q1 2022 May 05, 2022	BUY	$7.33 - $9.39 $199,595 - $255,689	27,230 New	27,230 $256,000
Q4 2020 Jan 26, 2021	SELL	$8.61 - $11.04 $100,650 - $129,057	-11,690 Closed	0 $0
Q3 2020 Oct 23, 2020	SELL	$8.57 - $12.69 $85,280 - $126,278	-9,951 Reduced 45.98%	11,690 $105,000
Q2 2020 Aug 14, 2020	BUY	$8.12 - $13.12 $175,724 - $283,929	21,641 New	21,641 $267,000
Q2 2019 Aug 05, 2019	SELL	$8.12 - $15.72 $111,812 - $216,464	-13,770 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$15.58 - $20.01 $7,930 - $10,185	-509 Reduced 3.56%	13,770 $216,000
Q4 2018 Feb 05, 2019	SELL	$14.59 - $23.84 $37,685 - $61,578	-2,583 Reduced 15.32%	14,279 $220,000
Q3 2018 Nov 13, 2018	SELL	$21.06 - $25.65 $126,359 - $153,900	-6,000 Reduced 26.24%	16,862 $363,000
Q2 2018 Aug 08, 2018	BUY	$16.77 - $24.71 $38,101 - $56,141	2,272 Added 11.03%	22,862 $556,000
Q1 2018 May 11, 2018	SELL	$16.68 - $22.07 $612,339 - $810,211	-36,711 Reduced 64.07%	20,590 $352,000
Q4 2017 Feb 12, 2018	SELL	$11.23 - $19.1 $561,859 - $955,611	-50,032 Reduced 46.61%	57,301 $1.09 Million
Q3 2017 Nov 13, 2017	SELL	$15.41 - $32.17 $789,716 - $1.65 Million	-51,247 Reduced 32.32%	107,333 $1.89 Million
Q2 2017 Aug 09, 2017	BUY	N/A	158,580	158,580 $5.27 Million

625

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $25.1B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Pinnacle Associates LTD, based on Form 13F filings with the SEC.

Stay updated on Pinnacle Associates LTD with notifications on news.